Atlas Trials

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

Clinical trial NCT05186805 · COMPLETED

Trial details

NCT number
NCT05186805
Sponsor
Organon and Co
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2021-11-15
Primary completion
2022-08-24
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.